FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616941315> ?p ?o ?g. }

• W2616941315 endingPage "1196" @default.
• W2616941315 startingPage "1189" @default.
• W2616941315 abstract "Abstract Background Pro-inflammatory and coagulation factors serve as biomarkers of aging and functional reserve. The purpose of this study was to determine if pro-inflammatory (interleukin-6 [IL-6], C-reactive protein [CRP]), and coagulation (D-dimer) factors were associated with pre-chemotherapy functional status in women with stage I–III breast cancer. Patients and Methods Prior to chemotherapy initiation in patients with stage I–III breast cancer, the following was captured: IL-6, CRP, D-dimer blood levels, and physical function measures including activities of daily living (ADL, subscale of Medical Outcomes Study Physical Health); instrumental activities of daily living (IADL, subscale of the Older Americans Resources and Services Program); Timed Up and Go (TUG); physician-rated Karnofsky Performance Status (KPS); and self-rated KPS. The association of these biomarkers with physical function measures was evaluated. Results One hundred sixty patients (mean age 58.3 years, range 30–81 years) with stage I–III breast cancer (stages I [n = 34; 21.5%], II [n = 88; 55.7%], III [n = 36; 22.8%]) were enrolled. The group with poorest physical function (defined by ADL &lt;70, IADL &lt;14, and TUG ≥10 seconds) had higher levels of IL-6 (p = .05), D-dimer (p = .0004), and CRP (p = .05). There was no significant association between these biomarkers and KPS. Patients with at least two biomarkers in the highest quartile were more likely to have poorer physical function (odds ration [OR] 18.75, p &lt; .001). In multivariate analysis adjusting for age, stage, number of comorbidities, and body mass index, the association remained (OR 14.6, p = .002). Conclusion Pre-chemotherapy biomarkers of aging are associated with poorer physical function among patients with breast cancer across the aging spectrum. The Oncologist 2017;22:1189–1196" @default.
• W2616941315 created "2017-06-05" @default.
• W2616941315 creator A5005344580 @default.
• W2616941315 creator A5005473474 @default.
• W2616941315 creator A5009303158 @default.
• W2616941315 creator A5010117707 @default.
• W2616941315 creator A5011540763 @default.
• W2616941315 creator A5013372598 @default.
• W2616941315 creator A5014173403 @default.
• W2616941315 creator A5023917993 @default.
• W2616941315 creator A5024549610 @default.
• W2616941315 creator A5037942451 @default.
• W2616941315 creator A5039755806 @default.
• W2616941315 creator A5041339246 @default.
• W2616941315 creator A5041448171 @default.
• W2616941315 creator A5047163487 @default.
• W2616941315 creator A5056569468 @default.
• W2616941315 creator A5056971354 @default.
• W2616941315 creator A5058983441 @default.
• W2616941315 creator A5068932647 @default.
• W2616941315 creator A5071179859 @default.
• W2616941315 creator A5086123605 @default.
• W2616941315 creator A5087277907 @default.
• W2616941315 date "2017-05-30" @default.
• W2616941315 modified "2023-10-06" @default.
• W2616941315 title "Association of Pre‐Chemotherapy Peripheral Blood Pro‐Inflammatory and Coagulation Factors with Physical Function in Women with Breast Cancer" @default.
• W2616941315 cites W1553634341 @default.
• W2616941315 cites W1580812738 @default.
• W2616941315 cites W1581939210 @default.
• W2616941315 cites W1822598714 @default.
• W2616941315 cites W1961026612 @default.
• W2616941315 cites W1994696327 @default.
• W2616941315 cites W2013600972 @default.
• W2616941315 cites W2045806344 @default.
• W2616941315 cites W2051903154 @default.
• W2616941315 cites W2052623206 @default.
• W2616941315 cites W2116992804 @default.
• W2616941315 cites W2126729859 @default.
• W2616941315 cites W2128118436 @default.
• W2616941315 cites W2129594345 @default.
• W2616941315 cites W2131553129 @default.
• W2616941315 cites W2145859123 @default.
• W2616941315 cites W2147056033 @default.
• W2616941315 cites W2149814390 @default.
• W2616941315 cites W2150751047 @default.
• W2616941315 cites W2154221980 @default.
• W2616941315 cites W2155758656 @default.
• W2616941315 cites W2155999435 @default.
• W2616941315 cites W2159745992 @default.
• W2616941315 cites W2162034682 @default.
• W2616941315 cites W2164059021 @default.
• W2616941315 cites W2166127731 @default.
• W2616941315 cites W2167527499 @default.
• W2616941315 cites W48451113 @default.
• W2616941315 doi "https://doi.org/10.1634/theoncologist.2016-0391" @default.
• W2616941315 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5634764" @default.
• W2616941315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28559409" @default.
• W2616941315 hasPublicationYear "2017" @default.
• W2616941315 type Work @default.
• W2616941315 sameAs 2616941315 @default.
• W2616941315 citedByCount "2" @default.
• W2616941315 countsByYear W26169413152020 @default.
• W2616941315 countsByYear W26169413152023 @default.
• W2616941315 crossrefType "journal-article" @default.
• W2616941315 hasAuthorship W2616941315A5005344580 @default.
• W2616941315 hasAuthorship W2616941315A5005473474 @default.
• W2616941315 hasAuthorship W2616941315A5009303158 @default.
• W2616941315 hasAuthorship W2616941315A5010117707 @default.
• W2616941315 hasAuthorship W2616941315A5011540763 @default.
• W2616941315 hasAuthorship W2616941315A5013372598 @default.
• W2616941315 hasAuthorship W2616941315A5014173403 @default.
• W2616941315 hasAuthorship W2616941315A5023917993 @default.
• W2616941315 hasAuthorship W2616941315A5024549610 @default.
• W2616941315 hasAuthorship W2616941315A5037942451 @default.
• W2616941315 hasAuthorship W2616941315A5039755806 @default.
• W2616941315 hasAuthorship W2616941315A5041339246 @default.
• W2616941315 hasAuthorship W2616941315A5041448171 @default.
• W2616941315 hasAuthorship W2616941315A5047163487 @default.
• W2616941315 hasAuthorship W2616941315A5056569468 @default.
• W2616941315 hasAuthorship W2616941315A5056971354 @default.
• W2616941315 hasAuthorship W2616941315A5058983441 @default.
• W2616941315 hasAuthorship W2616941315A5068932647 @default.
• W2616941315 hasAuthorship W2616941315A5071179859 @default.
• W2616941315 hasAuthorship W2616941315A5086123605 @default.
• W2616941315 hasAuthorship W2616941315A5087277907 @default.
• W2616941315 hasBestOaLocation W26169413151 @default.
• W2616941315 hasConcept C121608353 @default.
• W2616941315 hasConcept C126322002 @default.
• W2616941315 hasConcept C143998085 @default.
• W2616941315 hasConcept C156957248 @default.
• W2616941315 hasConcept C1862650 @default.
• W2616941315 hasConcept C38180746 @default.
• W2616941315 hasConcept C44249647 @default.
• W2616941315 hasConcept C530470458 @default.
• W2616941315 hasConcept C68443243 @default.
• W2616941315 hasConcept C71924100 @default.
• W2616941315 hasConcept C79544238 @default.
• W2616941315 hasConceptScore W2616941315C121608353 @default.

• next